Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 2021. Issue 2 (March 2022)

• Record Type: Journal Article
• Authors: Sonawane, Akshay; Vadloori, Bharadwaja; Poosala, Suresh; Kandarova, Helena; Kulkarni, Mandar; Olayanju, Adedamola; Dey, Tuli; Saxena, Uday; Smirnova, Lena; Kanda, Yasunari; Reddy, Jaganmohan; Dravida, Subhadra; Biswas, Saikat; Vinken, Mathieu; Gettayacamin, Montip; Ahluwalia, Arti; Mondini, Franco; Bhattacharya, Somshuvra; Kulkarni, Pushkar; Jacobsen, Kirsten Rosenmay; Vangala, Subrahmanyam; Millás, Ana Luiza
• Is Part Of: ATLA. Volume 50:Issue 2(2022)
• Page Start: 156
• Page End: 171
• Publication Date: 2022-03
• Subjects: 3Rs -- animal alternatives -- animal welfare -- disease models -- in vitro -- new approach methodologies -- organoids -- spheroids -- Three Rs; Laboratory animals -- Periodicals; 616.0273
• DOI: 10.1177/02611929221089216
• Languages: English
• ISSNs: 0261-1929

Abstract

The fact that animal models fail to replicate human disease faithfully is now being widely accepted by researchers across the globe. As a result, they are exploring the use of alternatives to animal models. The time has come to refine our experimental practices, reduce the numbers and eventually replace the animals used in research with human-derived and human-relevant 3-D disease models. Oncoseek Bio-Acasta Health, which is an innovative biotechnology start-up company based in Hyderabad and Vishakhapatnam, India, organises an annual International Conference on 3Rs Research and Progress. In 2021, this conference was on 'Advances in Research Animal Models and Cutting-Edge Research in Alternatives'. This annual conference is a platform that brings together eminent scientists and researchers from various parts of the world, to share recent advances from their research in the field of alternatives to animals including new approach methodologies, and to promote practices to help refine animal experiments where alternatives are not available. This report presents the proceedings of the conference, which was held in hybrid mode (i.e. virtual and in-person) in November 2021.